Stenocare AS (STENO) - Total Liabilities
Based on the latest financial reports, Stenocare AS (STENO) has total liabilities worth Dkr2.85 Million DKK (≈ $446.55K USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Stenocare AS annual equity growth to track the company's year-over-year net asset growth rate.
Stenocare AS - Total Liabilities Trend (2018–2025)
This chart illustrates how Stenocare AS's total liabilities have evolved over time, based on quarterly financial data. See STENO free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Stenocare AS Competitors by Total Liabilities
The table below lists competitors of Stenocare AS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
tokentus investment AG
MU:14D
|
Germany | €158.49K |
|
GENINCODE PLC LS -01
F:9PL
|
Germany | €1.56 Million |
|
NGS Group AB (publ)
ST:NGS
|
Sweden | Skr55.14 Million |
|
Solis Minerals Ltd
V:SLMN
|
Canada | CA$505.04K |
|
Mexican Gold Corp
V:MEX
|
Canada | CA$134.27K |
|
Truscreen Group Ltd
AU:TRU
|
Australia | AU$951.80K |
|
James Halstead PLC
LSE:JHD
|
UK | GBX58.12 Million |
|
Polar Power Inc
NASDAQ:POLA
|
USA | $9.06 Million |
Liability Composition Analysis (2018–2025)
This chart breaks down Stenocare AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see STENO market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Stenocare AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Stenocare AS (2018–2025)
The table below shows the annual total liabilities of Stenocare AS from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Dkr3.17 Million ≈ $495.94K |
-86.32% |
| 2024-12-31 | Dkr23.17 Million ≈ $3.62 Million |
+88.35% |
| 2023-12-31 | Dkr12.30 Million ≈ $1.92 Million |
-20.45% |
| 2022-12-31 | Dkr15.46 Million ≈ $2.42 Million |
+318.65% |
| 2021-12-31 | Dkr3.69 Million ≈ $577.82K |
-2.03% |
| 2020-12-31 | Dkr3.77 Million ≈ $589.82K |
-79.21% |
| 2019-12-31 | Dkr18.13 Million ≈ $2.84 Million |
+1364.32% |
| 2018-12-31 | Dkr1.24 Million ≈ $193.75K |
-- |
About Stenocare AS
Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD, as well as CBD100 oil products. The company was incorporated in 2017 and is based in Randers, Denmark.